Myoclonic disorders: A practical approach for diagnosis and treatment

Therapeutic Advances in Neurological Disorders

Volumn 4, Issue 1, 2011, Pages 47-62

  Kojovic, Maja ^a   Cordivari, Carla ^b   Bhatia, Kailash ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

classification; clinical approach; myoclonus; treatment

Indexed keywords

ANTIARRHYTHMIC AGENT; BENZODIAZEPINE; BISMUTH SALICYLATE; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CEPHALOSPORIN; CLONAZEPAM; CLOZAPINE; CONTRAST MEDIUM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; LEVODOPA; LITHIUM; MONOAMINE OXIDASE INHIBITOR; OPIATE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PREGABALIN; PRIMIDONE; PROPOFOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AICARDI SYNDROME; ALEXANDER DISEASE; ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ARBOVIRUS ENCEPHALITIS; ATAXIA TELANGIECTASIA; AUTOIMMUNE DISEASE; BIOTIN DEFICIENCY; BODY POSTURE; CELIAC DISEASE; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; CORTICAL MYOCLONUS; CORTICOBASAL DEGENERATION; CRYPTOCOCCUS; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DIALYSIS SYNDROME; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; DRUG DOSE TITRATION; DRUG MEGADOSE; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; EOSINOPHILIC ENCEPHALOPATHY; EPIDEMIC ENCEPHALITIS; EPILEPSY; EPILEPTIC MYOCLONUS; ESSENTIAL MYOCLONUS; FAMILY HISTORY; FRIEDREICH ATAXIA; FRONTOTEMPORAL DEMENTIA; GAUCHER DISEASE; GENERALIZED EPILEPSY; GLOBOID CELL LEUKODYSTROPHY; HASHIMOTO ENCEPHALOPATHY; HEMIFACIAL SPASM; HEREDITARY ESSENTIAL MYOCLONUS; HERPES SIMPLEX ENCEPHALITIS; HICCUP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUNTINGTON CHOREA; HYPEREKPLEXIA; HYPERTHYROIDISM; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOXIA; INFANTILE SPASM; INTESTINE LIPODYSTROPHY; JUVENILE MYOCLONIC EPILEPSY; KIDNEY FAILURE; LENNOX GASTAUT SYNDROME; LIVER FAILURE; LYME DISEASE; MALARIA; MERRF SYNDROME; METABOLIC ALKALOSIS; METABOLIC DISORDER; MUSCLE CONTRACTION; MUSCLE SPASM; MYELITIS; MYOCLONIC ABSCENCE SEIZURE; MYOCLONIC ASTATIC EPILEPSY; MYOCLONUS; MYOCLONUS DYSTONIA; MYOCLONUS EPILEPSY; NEGATIVE MYOCLONUS; NEURONAL CEROID LIPOFUSCINOSIS; NONKETOTIC HYPERGLYCEMIA; NONSEGMENTAL SUBCORTICAL MYOCLONUS; ONSET AGE; PALATE MYOCLONUS; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PARKINSON DISEASE; PERIPHERAL MYOCLONUS; PHYSIOLOGICAL MYOCLONUS; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RUMSAY HUNT SYNDROME; SEGMENTAL MYOCLONUS; SEGMENTAL SUBCORTICAL MYOCLONUS; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SHY DRAGER SYNDROME; SIALIDOSIS; SPINAL CORD INJURY; SPINAL MYOCLONUS; SPINOCEREBELLAR DEGENERATION; STARTLE REFLEX; SUBACUTE SCLEROSING PANENCEPHALITIS; SUBCORTICAL MYOCLONUS; SYPHILIS; SYRINGOMYELIA; TAY SACHS DISEASE; TREMOR; VIRUS ENCEPHALITIS; WILSON DISEASE;

EID: 79251479743     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285610395653     Document Type: Review

References (76)

1. Adam O.R. Ferrara J.M. Jankovic J. (2009) Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord 24: 2030–2032.
2. Alvarez M. Caviness J.N. (2008) Primary progressive myoclonus of aging. Mov Disord 23: 1658–1664.
3. Badhwar A. Berkovic S.F. Dowling J.P. Gonzales M. Narayanan S. Brodtmann A. et al (2004) Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder. Brain 127: 2173–2182.
4. Bien C.G. Elger C.E. (2008) Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord 10: 3–7.
5. Blanz J. Groth J. Zachos C. Wehling C. Saftig P. Schwake M. (2010) Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. Hum Mol Genet 19: 563–572.
6. Borg M. (2006) Symptomatic myoclonus. Neurophysiol Clin 36: 309–318.
7. Brown P. (1996) Myoclonus. Curr Opin Neurol 9: 314–316.
8. Brown P. Day B.L. Rothwell J.C. Thompson P.D. Marsden C.D. (1991 a) Intrahemispheric and interhemispheric spread of cerebral cortical myoclonic activity and its relevance to epilepsy. Brain 114: 2333–2351.
9. Brown P. Ridding M.C. Werhahn K.J. Rothwell J.C. Marsden C.D. (1996) Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain 119: 309–317.
10. Brown P. Rothwell J.C. Thompson P.D. Britton T.C. Day B.L. Marsden C.D. (1991 b) The hyperekplexias and their relationship to the normal startle reflex. Brain 114: 1903–1928.
11. Brown P. Rothwell J.C. Thompson P.D. Marsden C.D. (1994) Propriospinal myoclonus: evidence for spinal “pattern” generators in humans. Mov Disord 9: 571–576.
12. Capovilla G. Beccaria F. Veggiotti P. Rubboli G. Meletti S. Tassinari C.A. (1999) Ethosuximide is effective in the treatment of epileptic negative myoclonus in childhood partial epilepsy. J Child Neurol 14: 395–400.
13. Caviness J.N. (2007) Parkinsonism and related disorders. Myoclonus. Parkinsonism Relat Disord 13(Suppl. 3): S375–S384.
14. Caviness J.N. (2009) Pathophysiology and treatment of myoclonus. Neurol Clin 27: 757–777, vii.
15. Caviness J.N. Adler C.H. Beach T.G. Wetjen K.L. Caselli R.J. (2002) Small-amplitude cortical myoclonus in Parkinson's disease: physiology and clinical observations. Mov Disord 17: 657–662.
16. Caviness J.N. Adler C.H. Caselli R.J. Hernandez J.L. (2003) Electrophysiology of the myoclonus in dementia with Lewy bodies. Neurology 60: 523–524.
17. Caviness J.N. Brown P. (2004) Myoclonus: current concepts and recent advances. Lancet Neurol 3: 598–607.
18. Chadwick D. French A.T. (1979) Uraemic myoclonus: an example of reticular reflex myoclonus? J Neurol Neurosurg Psychiatry 42: 52–55.
19. Cif L. Valente E.M. Hemm S. Coubes C. Vayssiere N. Serrat S. et al (2004) Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 19: 724–727.
20. Costa J. Espirito-Santo C. Borges A. Ferreira J.J. Coelho M. Moore P. et al (2005) Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev 1: CD004899–CD004899.
21. Defebvre L. (2006) Myoclonus and extrapyramidal diseases. Neurophysiol Clin 36: 319–325.
22. Deuschl G. Lohle E. Heinen F. Lucking C. (1991) Ear click in palatal tremor: its origin and treatment with botulinum toxin. Neurology 41: 1677–1679.
23. Deuschl G. Mischke G. Schenck E. Schulte-Monting J. Lucking C.H. (1990) Symptomatic and essential rhythmic palatal myoclonus. Brain 113: 1645–1672.
24. Deuschl G. Toro C. Hallett M. (1994) Symptomatic and essential palatal tremor. 2. Differences of palatal movements. Mov Disord 9: 676–678.
25. Esposito M. Edwards M.J. Bhatia K.P. Brown P. Cordivari C. (2009) Idiopathic spinal myoclonus: a clinical and neurophysiological assessment of a movement disorder of uncertain origin. Mov Disord 24: 2344–2349.
26. Gelisse P. Crespel A. Genton P. Baldy-Moulinier M. (2003) Dramatic effect of levetiracetam on epileptic negative myoclonus. Acta Neurol Scand 107: 302–303.
27. Genton P. Gelisse P. (2000) Antimyoclonic effect of levetiracetam. Epileptic Disord 2: 209–212.
28. Glass G.A. Ahlskog J.E. Matsumoto J.Y. (2007) Orthostatic myoclonus: a contributor to gait decline in selected elderly. Neurology 68: 1826–1830.
29. Gordon M.F. (2002) Toxin and drug-induced myoclonus. Adv Neurol 89: 49–76.
30. Grabowski M. Zimprich A. Lorenz-Depiereux B. Kalscheuer V. Asmus F. Gasser T. et al (2003) The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 11: 138–144.
31. Grosse P. Kuhn A. Cordivari C. Brown P. (2003) Coherence analysis in the myoclonus of corticobasal degeneration. Mov Disord 18: 1345–1350.
32. Guerrini R. Bonanni P. Patrignani A. Brown P. Parmeggiani L. Grosse P. et al (2001) Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2. Brain 124: 2459–2475.
33. Hallett M. Chadwick D. Marsden C.D. (1979) Cortical reflex myoclonus. Neurology 29: 1107–1125.
34. Hess C.W. Raymond D. Aguiar Pde C. Frucht S. Shriberg J. Heiman G.A. et al (2007) Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 68: 522–524.
35. Howard K.L. Hall D.A. Moon M. Agarwal P. Newman E. Brenner M. (2008) Adult-onset Alexander disease with progressive ataxia and palatal tremor. Mov Disord 23: 118–122.
36. Ikeda A. Shibasaki H. Tashiro K. Mizuno Y. Kimura J. (1996) Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus / Piracetam Study Group. Mov Disord 11: 691–700.
37. Jankovic J. Pardo R. (1986) Segmental myoclonus. Clinical and pharmacologic study. Arch Neurol 43: 1025–1031.
38. Kakigi R. Shibasaki H. (1987) Generator mechanisms of giant somatosensory evoked potentials in cortical reflex myoclonus. Brain 110: 1359–1373.
39. Keswani S.C. Kossoff E.H. Krauss G.L. Hagerty C. (2002) Amelioration of spinal myoclonus with levetiracetam. J Neurol Neurosurg Psychiatry 73: 457–458.
40. Kimber T.E. Thompson P.D. (1997) Symptomatic hyperekplexia occurring as a result of pontine infarction. Mov Disord 12: 814–816.
41. Koukouni V. Valente E.M. Cordivari C. Bhatia K.P. Quinn N.P. (2008) Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp. Mov Disord 23: 1913–1915.
42. Kyllerman M. Ben-Menachem E. (1998) Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients. Epilepsy Res 29: 109–114.
43. Lagueny A. Tison F. Burbaud P. Le Masson G. Kien P. (1999) Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A. Mov Disord 14: 182–185.
44. Leppik I.E. (1999) Zonisamide. Epilepsia 40(Suppl. 5): S23–S29.
45. Li J.Y. Cunic D.I. Paradiso G. Gunraj C. Pal P.K. Lang A.E. et al (2008) Electrophysiological features of myoclonus-dystonia. Mov Disord 23: 2055–2061.
46. Magarinos-Ascone C.M. Regidor I. Martinez-Castrillo J.C. Gomez-Galan M. Figueiras-Mendez R. (2005) Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 76: 989–991.
47. Marsden C.D. Hallett M. Fahn S. (1982) The nosology and pathophysiology of myoclonus, In: Ed. Marsden C.D. Fahn S. (eds), Movement Disorders. Butterworths: London, pp. 196–248.
48. Misbahuddin A. Placzek M. Lennox G. Taanman J.W. Warner T.T. (2007) Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Mov Disord 22: 1173–1175.
49. Muller B. Hedrich K. Kock N. Dragasevic N. Svetel M. Garrels J. et al (2002) Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71: 1303–1311.
50. Pareyson D. Fancellu R. Mariotti C. Romano S. Salmaggi A. Carella F. et al (2008) Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 131: 2321–2331.
51. Pearce J.M. (2008) Palatal Myoclonus (syn. Palatal Tremor). Eur Neurol 60: 312–315.
52. Penney S.E. Bruce I.A. Saeed S.R. (2006) Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol 253: 857–860.
53. Plaster N.M. Uyama E. Uchino M. Ikeda T. Flanigan K.M. Kondo I. et al (1999) Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24. Neurology 53: 1180–1183.
54. Priori A. Bertolasi L. Pesenti A. Cappellari A. Barbieri S. (2000) gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia. Neurology 54: 1706–1707.
55. Ritz K. Gerrits M.C. Foncke E.M. van Ruissen F. van der Linden C. Vergouwen M.D. et al (2009) Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry 80: 653–658.
56. Rodriguez M.E. Artieda J. Zubieta J.L. Obeso J.A. (1994) Reflex myoclonus in olivopontocerebellar atrophy. J Neurol Neurosurg Psychiatry 57: 316–319.
57. Roze E. Apartis E. Clot F. Dorison N. Thobois S. Guyant-Marechal L. et al (2008) Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 70: 1010–1016.
58. Rubboli G. Tassinari C.A. (2006) Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management. Neurophysiol Clin 36: 337–343.
59. Ruprecht K. Warmuth-Metz M. Waespe W. Gold R. (2002) Symptomatic hyperekplexia in a patient with multiple sclerosis. Neurology 58: 503–504.
60. Samuel M. Torun N. Tuite P.J. Sharpe J.A. Lang A.E. (2004) Progressive ataxia and palatal tremor (PAPT): clinical and MRI assessment with review of palatal tremors. Brain 127: 1252–1268.
61. Saunders-Pullman R. Shriberg J. Heiman G. Raymond D. Wendt K. Kramer P. et al (2002) Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 58: 242–245.
62. Shahwan A. Farrell M. Delanty N. (2005) Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 4: 239–248.
63. Shiang R. Ryan S.G. Zhu Y.Z. Hahn A.F. O'Connell P. Wasmuth J.J. (1993) Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5: 351–358.
64. Shibasaki H. (1995) Pathophysiology of negative myoclonus and asterixis. Adv Neurol 67: 199–209.
65. Shibasaki H. (2006) Neurophysiological classification of myoclonus. Neurophysiol Clin 36: 267–269.
66. Shibasaki H. Hallett M. (2005) Electrophysiological studies of myoclonus. Muscle Nerve 31: 157–174.
67. Shibasaki H. Neshige R. (1987) Photic cortical reflex myoclonus. Ann Neurol 22: 252–257.
68. Tatu L. Moulin T. Martin V. Monnier G. Rumbach L. (2000) Unilateral pure thalamic asterixis: clinical, electromyographic, and topographic patterns. Neurology 54: 2339–2342.
69. Thompson P.D. Bhatia K.P. Brown P. Davis M.B. Pires M. Quinn N.P. et al (1994 a) Cortical myoclonus in Huntington's disease. Mov Disord 9: 633–641.
70. Thompson P.D. Day B.L. Rothwell J.C. Brown P. Britton T.C. Marsden C.D. (1994 b) The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 117: 1197–1207.
71. Trottenberg T. Meissner W. Kabus C. Arnold G. Funk T. Einhaupl K.M. et al (2001) Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. Mov Disord 16: 769–771.
72. van der Salm S.M. Koelman J.H. Henneke S. van Rootselaar A.F. Tijssen M.A. (2010) Axial jerks: a clinical spectrum ranging from propriospinal to psychogenic myoclonus. J Neurol 257: 1349–1355.
73. Werhahn K.J. Brown P. Thompson P.D. Marsden C.D. (1997) The clinical features and prognosis of chronic posthypoxic myoclonus. Mov Disord 12: 216–220.
74. Williams D.R. Cowey M. Tuck K. Day B. (2008) Psychogenic propriospinal myoclonus. Mov Disord 23: 1312–1313.
75. Wills A.J. Sawle G.V. Guilbert P.R. Curtis A.R. (2002) Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry 73: 91–92.
76. Zimprich A. Grabowski M. Asmus F. Naumann M. Berg D. Bertram M. et al (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29: 66–69.